FDA 483 - Aurobindo Pharma USA Inc - June 15, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The provided document content is incomplete, consisting solely of page number references without the actual text of the FDA 483 inspection report. Consequently, essential details such as the company name, specific inspection dates, identified violations or issues, the applicable regulatory framework, and any required corrective actions cannot be extracted or summarized. To provide a comprehensive and accurate summary as requested, the complete content of the FDA 483 document is necessary.
ID · bd6c21d0-cf5a-478a-b0e5-d85571f30522